When the U87MG cells transduced with the lentiviral vectors expressing shRNA targeting HSP90AA1-IT1 or non-targeting controls were subcutaneously implanted into the immunocompromised mice, we observed a significant decrease in tumor formation and an increase in the survival of tumor bearing mice when HSP90AA1-IT1 was targeted. This evidence concerns the gene HSP90AA1 and neoplasm.